Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Aliya™ Pulsed Electric Fields (PEF) for Advanced Cancer
- Conditions
- Lung Neoplasm Malignant
- First Posted Date
- 2023-06-06
- Last Posted Date
- 2025-08-20
- Lead Sponsor
- Galvanize Therapeutics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT05890872
- Locations
- 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
🇺🇸Mayo Clinic Rochester, Rochester, Minnesota, United States
🇺🇸Weill Cornell Medicine | New York-Presbyterian, New York, New York, United States
Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
- Conditions
- Soft Tissue Lesion
- First Posted Date
- 2023-05-09
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- Galvanize Therapeutics, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT05851430
- Locations
- 🇺🇸
Eisenhower Medical Center, Rancho Mirage, California, United States
🇺🇸New York Presbyterian Langone Health, New York, New York, United States
🇺🇸Duke University Hospital, Durham, North Carolina, United States
Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC
- Conditions
- NSCLC
- Interventions
- Device: Aliya Pulsed Electric Fields (PEF) ablationDrug: Standard of care neoadjuvant therapyOther: Surgical Resection
- First Posted Date
- 2022-10-17
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Galvanize Therapeutics, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT05583188
- Locations
- 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Temple University, Philadelphia, Pennsylvania, United States
A Clinical Evaluation of the Aliya™ System in Late Stage Cancer
- Conditions
- Cancer of Lung, Kidney or Liver
- First Posted Date
- 2021-02-26
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Galvanize Therapeutics, Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT04773275
- Locations
- 🇭🇰
Prince of Wales Hospital, Sha Tin, Hong Kong
🇳🇱Radboud University Medical Center, Nijmegen, Netherlands
🇪🇸Hospital Universitario de Salamanca, Salamanca, Spain
Feasibility Study of the Aliya System in the Treatment of Early Stage Non-small Cell Lung Cancer
- Conditions
- Non Small Cell Lung Cancer
- First Posted Date
- 2021-02-01
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Galvanize Therapeutics, Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT04732520
- Locations
- 🇭🇰
Prince of Wales Hospital, Sha Tin, Hong Kong
🇳🇱Radboud University Medical Center, Nijmegen, Netherlands
🇪🇸Fundacion Instituto de Investigation Sanitaria de la Fundacion Jimenez Diaz, Madrid, Spain